$8.47
89bio is a biotechnology business based in the US. 89bio shares (ETNB) are listed on the NASDAQ and all prices are listed in US Dollars. 89bio employs 70 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy 89bio stock
How to buy 89bio stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ETNB. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy 89bio stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
89bio stock price (NASDAQ: ETNB)
Use our graph to track the performance of ETNB stocks over time.89bio shares at a glance
Latest market close | $8.47 |
---|---|
52-week range | $6.58 - $18.25 |
50-day moving average | $8.47 |
200-day moving average | $9.57 |
Wall St. target price | $31.33 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-1.96 |
Is it a good time to buy 89bio stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
89bio price performance over time
Historical closes compared with the close of $8.47 from 2024-09-06
1 week (2024-08-30) | -10.84% |
---|---|
1 month (2024-08-07) | 9.86% |
3 months (2024-06-07) | 4.57% |
6 months (2024-03-07) | -34.95% |
1 year (2023-09-07) | -50.15% |
---|---|
2 years (2022-09-07) | 78.32% |
3 years (2021-09-07) | 19.56 |
5 years (2019-09-03) | N/A |
89bio financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -22.25% |
Return on equity TTM | -36.5% |
Profit margin | 0% |
Book value | $4.91 |
Market Capitalization | $1 billion |
TTM: trailing 12 months
89bio share dividends
We're not expecting 89bio to pay a dividend over the next 12 months.
89bio share price volatility
Over the last 12 months, 89bio's shares have ranged in value from as little as $6.575 up to $18.25. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while 89bio's is 0.998. This would suggest that 89bio's shares are less volatile than average (for this exchange).
89bio overview
89bio, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis; and for the treatment of severe hypertriglyceridemia. The company was incorporated in 2018 and is headquartered in San Francisco, California. .
Frequently asked questions
nullWhat percentage of 89bio is owned by insiders or institutions?
Currently 0.673% of 89bio shares are held by insiders and 102.058% by institutions. How many people work for 89bio?
Latest data suggests 70 work at 89bio. When does the fiscal year end for 89bio?
89bio's fiscal year ends in December. Where is 89bio based?
89bio's address is: 142 Sansome Street, San Francisco, CA, United States, 94104 What is 89bio's ISIN number?
89bio's international securities identification number is: US2825591033 What is 89bio's CUSIP number?
89bio's Committee on Uniform Securities Identification Procedures number is: 282559103
More guides on Finder
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
7 best day trading platforms of 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
Trading for beginners: 11 best trading platforms to get started
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
5 best international stock brokers to invest in foreign assets
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
-
9 best discount brokers of 2024 for low-cost trading and investing
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
-
10 best stock apps of 2024 to elevate your mobile trading
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
-
10 best brokerage accounts for buying stocks, options and more in 2024
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question